Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more
Fresenius Medical Care AG & Co. KGaA (FMCQF) - Total Assets
Latest total assets as of September 2025: $30.89 Billion USD
Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FMCQF) holds total assets worth $30.89 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Fresenius Medical Care AG & Co. KGaA - Total Assets Trend (1998–2024)
This chart illustrates how Fresenius Medical Care AG & Co. KGaA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Fresenius Medical Care AG & Co. KGaA - Asset Composition Analysis
Current Asset Composition (December 2024)
Fresenius Medical Care AG & Co. KGaA's total assets of $30.89 Billion consist of 23.6% current assets and 76.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.4% |
| Accounts Receivable | $3.92 Billion | 11.7% |
| Inventory | $2.07 Billion | 6.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.37 Billion | 4.1% |
| Goodwill | $15.17 Billion | 45.2% |
Asset Composition Trend (1998–2024)
This chart illustrates how Fresenius Medical Care AG & Co. KGaA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fresenius Medical Care AG & Co. KGaA's current assets represent 23.6% of total assets in 2024, a decrease from 25.1% in 1998.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2024, up from 0.6% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, a decrease from 61.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 45.2% of total assets.
Fresenius Medical Care AG & Co. KGaA Competitors by Total Assets
Key competitors of Fresenius Medical Care AG & Co. KGaA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Fresenius Medical Care AG & Co. KGaA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Fresenius Medical Care AG & Co. KGaA generates 0.58x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Fresenius Medical Care AG & Co. KGaA generates $ 1.60 in net profit.
Fresenius Medical Care AG & Co. KGaA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 1.37 | 1.18 |
| Quick Ratio | 1.00 | 1.02 | 0.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.06 Billion | $ 2.20 Billion | $ 1.11 Billion |
Fresenius Medical Care AG & Co. KGaA - Advanced Valuation Insights
This section examines the relationship between Fresenius Medical Care AG & Co. KGaA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.87 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $33.57 Billion |
| Market Capitalization | $9.48 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Fresenius Medical Care AG & Co. KGaA's assets below their book value (0.28 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Fresenius Medical Care AG & Co. KGaA's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Fresenius Medical Care AG & Co. KGaA (1998–2024)
The table below shows the annual total assets of Fresenius Medical Care AG & Co. KGaA from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $33.57 Billion | -1.07% |
| 2023-12-31 | $33.93 Billion | -5.10% |
| 2022-12-31 | $35.75 Billion | +4.04% |
| 2021-12-31 | $34.37 Billion | +8.45% |
| 2020-12-31 | $31.69 Billion | -3.78% |
| 2019-12-31 | $32.94 Billion | +25.50% |
| 2018-12-31 | $26.24 Billion | +9.23% |
| 2017-12-31 | $24.02 Billion | -6.19% |
| 2016-12-31 | $25.61 Billion | +9.66% |
| 2015-12-31 | $23.35 Billion | +11.60% |
| 2014-12-31 | $20.93 Billion | +24.99% |
| 2013-12-31 | $16.74 Billion | -0.82% |
| 2012-12-31 | $16.88 Billion | +12.02% |
| 2011-12-31 | $15.07 Billion | +17.25% |
| 2010-12-31 | $12.85 Billion | +16.40% |
| 2009-12-31 | $11.04 Billion | +3.03% |
| 2008-12-31 | $10.72 Billion | +10.27% |
| 2007-12-31 | $9.72 Billion | -1.67% |
| 2006-12-31 | $9.88 Billion | +46.64% |
| 2005-12-31 | $6.74 Billion | +14.76% |
| 2004-12-31 | $5.87 Billion | -1.42% |
| 2003-12-31 | $5.96 Billion | -7.79% |
| 2002-12-31 | $6.46 Billion | -11.77% |
| 2001-12-31 | $7.32 Billion | +15.04% |
| 2000-12-31 | $6.37 Billion | +11.36% |
| 1999-12-31 | $5.72 Billion | +18.05% |
| 1998-12-31 | $4.84 Billion | -- |